Community health worker coaches to support automated insulin delivery for Black children with type 1 diabetes
Official title: Utilizing a Community Health Worker in the Role of a Diabetes Technology Coach for Black Children Using Automated Insulin Delivery and Not Meeting Glycemic Targets (CHWs AID Youth)
Run by University Hospitals Cleveland Medical Center · NCT07154251 · Data updated 2026-11-12
This program will try having community health workers coach non-Hispanic Black children with type 1 diabetes who use automated insulin delivery to see if it helps their blood sugar control.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 16 (estimated) |
| Sponsor | University Hospitals Cleveland Medical Center Academic / other |
| Locations | 1 site (Cleveland, Ohio) |
| Status | Recruiting |
| Started | November 6, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | December 4, 2025 |
| Trial ID | NCT07154251 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non-Hispanic Black children with type 1 diabetes who currently use or used an automated insulin delivery system within the past 3 months, have an HbA1c of about 8% or higher, receive care at University Hospitals Cleveland Medical Center, and have English-speaking guardians willing to participate.
✕Probably not a fit
Patients who are non-English-speaking, have type 2 or monogenic diabetes, have already worked with a community health worker for diabetes technology, are not using automated insulin delivery recently, or cannot attend visits at UH Cleveland are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Non-Hispanic Black children with type 1 diabetes who are using an automated insulin delivery system will meet with a trained community health worker monthly for six months, with extra visits as needed. Participants and their parents or guardians will complete questionnaires at the start and end of the six-month coaching period and will take part in an interview at six months. After the coaching period, the team will continue to collect continuous glucose monitor and pump download data for an additional six months without extra CHW support. Care must be provided at University Hospitals Cleveland Medical Center and guardians must be English-speaking and willing to participate.
Why it matters
Potential benefit: If successful, this approach could improve glucose control, increase confidence using diabetes technology, and help reduce outcome disparities for Black children with type 1 diabetes.
How similar studies have gone: Community health worker programs have improved diabetes care in other populations, but using CHWs specifically as coaches for automated insulin delivery in Black children is a relatively novel approach with limited direct evidence to date.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-reported as non-Hispanic Black * Clinical diagnosis of type 1 diabetes, requiring treatment with insulin at the time of consent * Currently using, or have used within the past 3 months, an automated insulin delivery system (consisting of a continuous glucose monitor and an insulin pump as well as an automated insulin delivery algorithm) * Clinical care provided at UH Cleveland Medical Center * Has not previously worked with a community health worker for help with diabetes technology Exclusion Criteria: * Clinical diagnosis of Type 2 or monogenic diabetes * Completed high school * At least 1 parent/guardian or family support person not willing to participate * Non-English speaking guardians * Has not used automated insulin delivery within the past 3 months * Has previously worked with a CHW for help with diabetes technology * Custody of children and family services
Where it's running
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States Recruiting
Study contacts
- Principal investigator: Sarah A MacLeish, DO — University Hospitals Cleveland Medical Center
- Study coordinator: Wendy Campbell, RN, CDCES
- Email: wendy.campbell@uhhospitals.org
- Phone: 216-844-3661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic
This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work
We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.
-
Islet re-transplantation after prior graft failure in adults with type 1 diabetes
This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.